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Abstract
Background: Allergen-specific IgE production is a hallmark of allergic asthma/rhinitis/eczema. Theoretically this
could be due to a high number of allergen-specific B cells or allergen-specific T cells helping allergen-specific B
cells differentiate into IgE-producing plasma cells. Here, we determined whether the number of allergen-specific B
cells or T helper (Th) cells is higher in allergic individuals compared to nonallergic individuals.
Methods: A total of 52 allergic individuals and 32 nonallergic individuals were studied. The allergen-specific B and
Th cells were enumerated by culturing CFSE-loaded blood mononuclear cells for 7-days with allergen (cat, Timothy
or birch), and determining the number of proliferating B or Th cells (diluting CFSE) by flow cytometry. Allergen-
specific IgE concentration was determined by fluorescent enzymoimmunoassay (FEIA).
Results: The quantities of proliferating Th cells but not proliferating B cells specific for cat, Timothy and birch were
significantly higher in cat-, Timothy- and birch-allergic individuals compared to nonallergic individuals. The titer of
allergen-specific IgE showed significant correlation with allergen-specific Th cells and not with allergen-specific B
cells for all 3 allergens.
Conclusions: A high number of allergen-specific proliferating Th cells, but not proliferating B cells, may play a role
in the pathogenesis of allergic asthma/rhinitis/eczema.
Background
Enhanced production of allergen-specific IgE is charac-
teristic for allergic asthma, rhinitis or eczema [1,2].
Upon inhalation, ingestion or transcutaneous diffusion
of the allergen, dendritic cells present peptides from the
allergen to allergen-specific Th cells. These allergen-spe-
cific Th cells, expressing CD40 ligand and secreting Th2
cytokines like IL-4, stimulate the differentiation of aller-
gen-specific B cells to IgE-producing plasma cells [3-6].
The increased production of IgE could be due to 1)
increased quantity of allergen-specific B cells, 2) abnor-
mal function of allergen-specific B cells (abnormally
high B cell-intrinsic drive to differentiate into IgE
plasma cells), 3) increased quantity of allergen-specific
Th cells, 4) abnormal function of allergen-specific Th
cells (abnormally high propensity to stimulate B cell dif-
ferentiation into IgE plasma cells, eg, through increased
secretion of Th2 cytokines), or 5) other mechanisms. To
determine whether the mechanism of increased B cell
quantity or the mechanism of increased Th cell quantity
may apply, here we compared the quantity of allergen-
specific proliferating B and Th cells for inhalant aller-
gens in allergic and nonallergic individuals. The term
allergen-specific Th cells or B cells has been used to
describe allergen-specific proliferating Th or B cells
throughout the manuscript. We also assessed the pro-
duction of IL-4 (characteristic of Th2 cells) and IFNg
(characteristic of Th1 cells) by the allergen-specific Th
cells.
Materials and methods
Subjects
Fifty-two allergic and 32 nonallergic individuals partici-
pated in the study. Allergic individuals were recruited by
allergists (B.S. or T.B.) among patients newly referred to
their allergy clinics. All 52 allergic individuals (38%
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asthma, rhinitis or eczema and were skin prick test
(SPT)-positive for at least 1 of 9 common inhalant aller-
gens tested (see below). Their median age was 27 years
(range, 18-69 years). Asymptomatic subjects (without
symptoms of asthma, rhinitis or eczema) were recruited
by advertising. They were included into the study as
“nonallergic subjects” only if they were SPT-negative for
all 9 inhalant allergens tested. We studied 32 nonallergic
individuals (40% male, n = 13; 60% female, n = 19); their
median age was 29 years (range, 15-47 years). During
each month of blood drawing from a non allergic indivi-
dual, blood was drawn also from 1-2 allergic individuals
to ensure season-matching of allergic and nonallergic
individuals.
To ensure uniformity in assessing the presence of
symptoms of asthma, rhinitis or eczema between the
symptomatic and asymptomatic persons, the Interna-
tional Study of Asthma and allergies in Childhood ques-
tionnaire (version Phase II, http://isaac.auckland.ac.nz/
PhaseOne/Manual/ManFrame.html, accessed December
27, 2007) was used for both the symptomatic and
asymptomatic subjects. Presence of symptoms was
defined as a positive answer to question No. 2, 7 or 8 of
the asthma section, question No. 2 of the rhinitis section
or question No. 2 of the eczema section of the question-
naire. Of the 52 allergic subjects, 14 (27%) had asthma,
rhinitis and eczema, 16 (31%) had asthma and rhinitis, 4
(7.5%) had rhinitis and eczema, 12 (23%) had rhinitis
only, 4 (7.5%) had asthma only, and 2 (4%) had eczema
only. Per another questionnaire, none of the allergic or
nonallergic subjects had had cancer, autoimmune dis-
ease or immune deficiency, had ever received allergen
immunotherapy or received systemic immunosuppres-
sive drugs in the previous three months. None of the
subjects received antihistamines in the last 7 days prior
to SPT. All subjects (allergics and nonallergics) signed a
written consent to participate in the study. The study
was approved by the Ethics Committee of the University
of Calgary.
Blood was drawn for allergen-specific B/Th cell assays
prior to SPT (typically within one hour prior to SPT) to
eliminate the possibility of SPT influence on the results
of the allergen-specific B/Th cell assays. Blood was
drawn at two different times from 5 allergic and 4 non-
allergic individuals to evaluate whether the quantity of
allergen specific B and Th cells differs in the same indi-
vidual at different time points.
Allergens
Allergen extracts (ALK-Abello, Horsholm, Denmark,
except for Timothy grass pollen extract from Greer
Laboratories, Lenoir, NC, USA) were kindly donated by
Western Allergy, Mississauga, Ontario, Canada. Neat
extracts contained 50% glycerol and 0.4% phenol. Nega-
tive control was 0.9% sodium chloride in 50% glycerol
and 0.4% phenol (Glycerol Saline). Positive control was
histamine 1 mg/mL in 50% glycerol and 0.4% phenol
(Histatrol, [ALK-Abello, Horsholm, Denmark]) for skin
prick test and monoclonal mouse-anti-human CD3
(mitogenic clone 64.1) for allergen-specific Th cells
assay. The same CD3 antibody was used also as a posi-
tive control for the allergen-specific B cell assay, as B
cell proliferation was induced in the CD3 antibody-
stimulated culture of mononuclear cells, probably by
stimulated T cells. The allergen concentration used for
SPT was in compliance with the US guidelines on prob-
able effective concentration range for allergen extracts
(http://www.aaaai.org/professionals/resources/immu-
notherapy/, accessed on November 26, 2008). The aller-
gen concentration used for allergen-specific B/Th cells
assay was based on our preliminary experiments in
which assay was performed for each allergen using three
different concentrations - 10-times, 100-times and 1000-
times lower concentration than that used for SPT. The
100-times lower concentration was associated with the
highest percentage of Th and B cell proliferation above
Glycerol Saline background. Thus, the final concentra-
tion used was as follows:
○ Cat pelt, 10,000 BAU/ml [SPT], 100 BAU/ml [spe-
cific B/Th cells]
○ Dog epithelium, 1:20 [SPT], 1:2000 [specific B/Th
cells]
○ Dermatophagoides pteronyssius (DP), 10000 AU/ml
[SPT], 100 AU/ml [specific B/Th cells]
○ Dermatophagoides farinae (DF), 10000 AU/ml
[SPT], 100 AU/ml [specific B/Th cells]
○ Alternaria, 1:10 [SPT], 1:1000 [specific B/Th cells]
○ Hormodendrum/Cladosporium, 1:10 [SPT], 1:1000
[specific B/Th cells]
○ Timothy grass pollen, 100,000 AU/ml [SPT], 1000
AU/ml [specific B/Th cells]
○ Short ragweed pollen, 1:20 [SPT], 1:2000 [specific
B/Th cells]
○ Birch tree (Betula verrucosa) pollen, 1:20 [SPT],
1:2000 [specific B/Th cells]
Enumeration of Allergen-Specific B, Th, Th1 and Th2 cells
(a) Cell culture and Flow analysis
Blood was drawn into heparinized tubes. Within 8 h
from the blood draw, mononuclear cells (MNCs) were
isolated using density gradient centrifugation (Ficoll,
density 1.073 kg/L) and labeled with 5 μM carboxyfluor-
escein diacetate succinimidyl ester (CFSE, Molecular
Probes). CFSE labeling was done to measure the prolif-
eration of allergen-specific Th and B cells. When a
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Page 2 of 12CFSE-labeled cell divides, CFSE-labeled proteins in the
cell are equally distributed between the daughter cells,
thus halving cell fluorescence with each division. Conse-
quently, dividing cells lose their fluorescence (become
CFSE
low), and non-proliferating cells preserve their
brightness (remain CFSE
high). The number of the origi-
nal cells can be calculated from estimated number of
divisions for each cell [7]. This allows the detection of
low frequency cells that can only be detected after they
have proliferated. Three million of CFSE-labeled MNCs
in 2 ml of DMEM-RS media (Hyclone, Logan, UT) sup-
plemented with 2 mM glutamine, Penicillin (100 U/ml),
Streptomycin (0.1 mg/ml), and 5% autologous plasma
were incubated with allergen (see “Allergens”,a b o v e ,f o r
concentration) or negative control (Glycerol Saline) or
positive control (anti-CD3) for 7 days at 37°C in a humi-
dified atmosphere containing 5% CO2. Monensin (Golgi-
stop, BD Biosciences; final concentration 2 mM) was
added into the cell culture on day 6 (for the last 18 h of
culture). At the end of culture, cells were washed using
PBS with 10% Fetal Bovine Serum and 2 mM EDTA,
resuspended in PBS, and fixed and permeabilized using
BD cytofix/cytoperm kit (BD Biosciences). Then the
cells were stained for 30 min at 4°C with the following
fluorochrome-labeled antibodies: IFNg-APC, CD4-APC-
Cy7 (Miltenyi Biotec, Bergisch Gladbach, Germany), IL-
4-PE, CD3-PC7 (BD Biosciences, San Jose, CA, USA)
and CD19-PC5 and CD20-PC5 (Beckman Coulter, Mis-
sissauga, Ontario, Canada). Cells were washed and
resuspended in PBS with 1% bovine serum albumin and
0.1% sodium azide. Immediately before flow cytometry,
a known number of fluorospheres (eg, 50,000) (Flow-
Count, Beckman Coulter) were added to each sample.
The cells were then analyzed by flow cytometry (FACS
A r i a ,B DB i o s c i e n c e s ,S a nJ o s e ,C A ,U S A ) .D a t aw e r e
analyzed using FACS DiVa software (BD Biosciences,
San Jose, CA, USA). Allergen-specific B cells were
defined as CFSE
low cells expressing CD19 or CD20.
Allergen-specific Th cells were defined as CFSE
low cells
e x p r e s s i n gC D 3a n dC D 4( F i g u r e1 ) .A l l e r g e n - s p e c i f i c
Negative Control  Negative Control 
(Glycerol Saline) (Glycerol Saline)
Positive Control  Positive Control 
(Anti CD3) (Anti CD3)
Allergen  Allergen 
(Timothy) (Timothy)
Allergen specific  Allergen specific 
Th Th cells cells
Allergen specific  Allergen specific 
Th1 cells Th1 cells
Allergen specific  Allergen specific 
Th2 cells Th2 cells
Allergen specific  Allergen specific 
B cells B cells
CD4 CD4
CFSE CFSE
IFN IFNγ γ γ γ γ γ γ γ
CFSE CFSE
IL4 IL4
CFSE CFSE
CD19  CD19 
and  and 
CD20 CD20
CFSE CFSE
P1
P2
P3
P4
Gated on
CD3+CD4+ 
cells
CD3+CD4+ 
cells
CD3+CD4+ 
cells
CD19+ 
and/or 
CD20+ cells
Figure 1 Example of allergen specific Th and B cells. Peripheral blood MNCs (in this example from Timothy-allergic individual per skin prick
test) labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE) were cultured for 7 days with Timothy allergen. Glycerol saline (negative
control) and anti-CD3 (positive control) were used as controls. Monensin was used to stop cytokine secretion. At the end of the culture, cells
were stained for CD3, CD4, CD19, CD20, IFNg and IL-4 and analyzed using FACS Aria flow cytometer. Timothy-specific Th, Th1, Th2 and B cells
are defined as CFSE
lowCD3
posCD4
pos (P1), CFSE
lowCD3
posCD4
posIFNg
pos (P2), CFSE
lowCD3
posCD4
pos IL-4
pos (P3) and CFSE
lowCD3
pos(CD19
pos or
CD20
pos) (P4) cells, respectively.
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low cells expressing CD3 and CD4 and either IFNg (Th1)
or IL-4 (Th2) (Figure 1).
(b) Index and absolute count of allergen specific B, Th, Th1
and Th2 cells
The method of calculation of index and absolute count
of allergen specific B, Th, Th1 and Th2 cells is dis-
played in Figure 2. The percentage of the CFSE
low cells
on day 7 of culture is referred to as the “index” of the
quantity of allergen-specific cells. The absolute count
of the allergen-specific cells was determined from the
absolute MNC count on day 0 (absolute lymphocyte
count + absolute monocyte count per ml of blood), the
acquired cell proportion on day 7 (determined as the
acquired proportion of fluorospheres, eg, 0.8 if 40,000
of the 50,000 fluorospheres were acquired), and the
number of precursor cells of acquired (by flow cytome-
try) allergen-specific cells (determined using Modfit
software, Verity Software House, see next paragraph
for details). The absolute count of allergen-specific
cells (per ml of blood) was calculated using the follow-
ing formula:
A=
Total number ofﬂ uorospheres in tube (eg, 50,000)
Acquired number of ﬂuorospheres (eg, 40,000)
×Number of precursor cells of acquired allergen−speciﬁc cells of the subset∗
*B cells, Th cells, Th1 cells or Th2 cells
The absolute count of allergen−speciﬁc cells (per ml of blood) = A×
Absolute MNC count on day 0 of culture (per ml blood)
Number of MNCs put into culture on day 0
The number of precursor cells of acquired allergen-
specific cells (the precursor cells of CFSE
low Th cells,
CFSE
low B cells, CFSE
low IFNg+ Th cells, CFSE
low IL-4
+ Th cells) was estimated using the ModFit software
(Verity Software House, Topsham, ME, USA). Based
on CFSE fluorescence, the software estimates how
many cells divided (between day 0 and day 7) once
(generation 1), twice (generation 2), three times (gen-
eration 3), etc. To exclude bystander responding cells
(which should undergo fewer divisions than allergen-
specific cells), only generations 3, 4, 5 and higher were
considered as the allergen-specific cells and
[ [# #7 7] ]   / /   2 2
7 7   + +   [ [# #6 6] ]   / /   2 2
6 6   + +   [ [# #5 5] ]   / /   2 2
5 5   + +   [ [# #4 4] ]   / /   2 2
4 4   + +
   [ [# #3 3] ]   / /   2 2
3 3   
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Figure 2 Example of calculation of the index of the quantity of allergen-specific Th cells and the number of precursor cells of
acquired allergen-specific cells (needed to calculate the absolute count of allergen specific Th cells). The percentage of the CFSE
low cells
after the 7 day culture is referred to as the “index” of the quantity of allergen-specific cells (in this example, Timothy-specific Th index). The
number of precursor cells of acquired allergen-specific cells (in this example, precursor cells of CFSE
low Th cells), determined using the ModFit
software, and was used to estimate the absolute count of allergen-specific Th cells. Only generations 3 and higher were considered as allergen-
specific cells and generations 0, 1 and 2 were omitted from the calculation.
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Page 4 of 12generations 0, 1 and 2 were omitted from the calcula-
tion (Figure 2). The number of precursor cells of
acquired allergen-specific cells was calculated as
([number of cells in generation 3]/2
3 +[ n u m b e ro f
cells in generation 4]/2
4 + [number of cells in genera-
tion 5]/2
5 + [number of cells in generation 6]/2
6 +
[number of cells in generation 7]/2
7 + [number of cells
in generation 8]/2
8).
To correct the index or the absolute count of allergen-
specific cells for background (eg, due to nonspecific sti-
mulation, nonspecific staining or loss of CFSE activity),
the index or the absolute count of the negative control
was subtracted. The indices and absolute counts pre-
sented in the Results and Figures 3 and 4 are the cor-
rected indices and corrected absolute counts.
Skin Prick Testing
Allergen drops and positive and negative control drops
were applied on the volar forearms with at least 2 cm
distance from each other. For each allergen, a single epi-
cutaneous prick was done using Allersharp
® device
(Western Allergy, Mississauga, Ontario, Canada). Wheal
area was recorded for Histatrol at 10 min, and for
others (each allergen and negative control) at 15 min by
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Figure 3 Indices for allergen-specific B cells (left) and Th cells (right) in allergic patients (n = 52, closed diamonds) and nonallergic
persons (n = 32, open diamonds). The numbers of allergic patients were 26 for cat, 34 for Timothy, and 27 for birch. Significance of the
difference between the allergic and nonallergic groups is given in the upper section of each plot. Allergen-specific Th and B cell results are
displayed as corrected percentage of CFSE low Th and B cells (saline control percentage subtracted). The horizontal bars show the medians.
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are displayed as corrected absolute count of CFSE low Th and B cells (saline control absolute counts subtracted). The horizontal bars show the
medians.
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Page 6 of 12outlining the area with a felt-tipped pen, and transfer-
ring the outline onto 3 M tapes to keep a permanent
record of SPT. The recorded wheal areas were scanned
as jpeg files and analyzed by Image J software (National
Institutes of Health, Bethesda, MD, USA) to determine
the average diameter of each wheal. The average dia-
meter of the negative control wheal was subtracted from
each allergen wheal (corrected diameter). The SPT
result was considered positive if the corrected diameter
was greater than 3 mm [8]. All subjects had a valid SPT
as defined by at least 1 mm diameter difference between
the positive and negative controls[8].
Fluorescent enzymoimmunoassay
Sera from the research subjects were stored in tightly
sealed vials at -86°C. Allergen-specific IgE concentra-
tion was determined using UniCAP100 instrument
and specific IgE FEIA reagents (Phadia, Uppsala, Swe-
den, accessed January 7, 2010) per manufacturer
instructions. Numbers of allergic and non-allergic
individuals tested for allergen-specific IgE are men-
tioned in Table 1.
Statistics
Significance of difference of test results (index or the
absolute count of allergen-specific T or B cells) between
2 subject groups was tested by Mann-Whitney-Wil-
coxon rank sum test. P values less than 0.05 (2-tailed)
were considered significant.
Results
Allergic and nonallergic individuals
By SPT, 26 (50%) of the 52 allergic subjects were allergic
to cat, 14 (27%) to dog, 11 (21%) to D. pteronyssimus,6
(11%) to D. farinae, 2 (4%) to Alternaria, 3 (6%) to Hor-
modendrum, 34 (65%) to Timothy, 27 (52%) to birch
a n d6( 1 1 % )t os h o r tr a g w e e d .G i v e nt h es m a l ln u m b e r
of subjects allergic to Dog, D. pteronyssimus, D. farinae,
Alternaria, Hormodendrum and short ragweed, only
analyses pertinent to cat, Timothy and birch are pre-
sented here. The indices of allergen-specific T/B cells
were determined in all 52 allergic and 32 nonallergic
individuals, whereas the absolute counts were
determined in only the last consecutive 33 allergic and
18 nonallergic individuals (Table 1).
Indices of allergen-specific B and Th cells
Indices of allergen-specific B cells were similar in indivi-
duals allergic to any of the allergens analyzed (cat,
Timothy, birch) compared to nonallergic individuals
(Figure 3, left). In contrast, the indices of allergen-speci-
fic Th cells were significantly higher in individuals aller-
gic to cat, Timothy or birch compared to nonallergic
individuals (Figure 3, right).
Absolute counts of allergen-specific B and Th cells
The indices presented in the previous paragraph are
imperfect indicators of the quantity of allergen-specific
B/Th cells. For example, a higher allergen-specific Th
cell index in allergic individuals could be due to the fact
that allergen-specific Th cells from allergic individuals
underwent on average more divisions in the culture
than allergen-specific Th cells from nonallergic indivi-
duals. The index also does not take into account poten-
tial differences in the absolute counts of total B or Th
cells in the blood of allergic and nonallergic individuals.
Thus, in a subset of the study subjects (the “n” for each
allergen is given in Table 1) we also determined the
absolute counts of allergen-specific B and Th cells.
Analogous to the indices, the absolute counts of aller-
gen-specific B cells were similar in individuals allergic to
any of the allergens analyzed compared to nonallergic
individuals (Figure 4, left). Also analogous to the indices,
t h ea b s o l u t ec o u n t so fa l l e r g e n - s p e c i f i cT hc e l l sw e r e
significantly higher in individuals allergic to cat,
Timothy or birch compared to nonallergic individuals
(Figure 4, right). We then compared the ratio of positive
control (anti CD3)-specific Th cell and allergen-specific
Th cells to rule out the impact of run variability. Similar
to the absolute counts of allergen-specific Th cells, the
ratio of positive control (anti CD3)-specific Th cell and
allergen-specific Th cells was significantly higher in indi-
viduals allergic to cat, Timothy or birch compared to
nonallergic individuals (Figure 5). The absolute counts
of Th and B cells were found similar in allergic indivi-
duals allergic to one and more than one allergen.
Table 1 Subjects (allergic and nonallergic) studied
Allergens Index Analysis Absolute count Analysis FEIA analysis
Allergic
Individuals
1
Nonallergic
Individuals
2
Allergic
Individuals
1
Nonallergic
Individuals
2
Allergic
Individuals
1
Nonallergic
Individuals
2
Cat 26 32 18 18 13 12
Timothy 34 32 23 18 11 12
Birch 27 32 19 18 12 12
1 Numbers denote the number of allergic individuals (with symptoms of asthma/rhinitis/eczema and skin prick test (SPT) positive for the specific allergen)
2 Numbers denote the number of nonallergic individuals (with no symptoms of asthma/rhinitis/eczema and SPT negative for all 9 allergens tested)
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of Th cells was allergen-specific, we performed an
additional analysis by dividing allergic patients into
those allergic to the allergen of interest (SPT result
positive for that allergen, “Allergic SPT+”)a n dt h o s e
allergic to a different allergen(s) ("Allergic SPT-”). For
example, cat allergen acts as a non-offending allergen
in CAT SPT- allergic individuals. The absolute counts
of allergen-specific Th cells were higher for all 3 aller-
gens tested in SPT+ than SPT- individuals (Additional
file 1, Figure S1). The difference was significant for
Timothy (P = 0.001) and showed a trend of signifi-
cance for birch (P = 0.06) and cat (P = 0.09). Also, the
absolute counts of Th cells specific for Timothy, birch
and cat were similar in SPT- and non-allergic indivi-
duals. In contrast to T cells, absolute counts of B cells
specific for Timothy, birch and cat were similar
between SPT+ and SPT-individuals, SPT+ and non-
allergic individuals and SPT- and non-allergic indivi-
duals (Additional file 1, Figure S1).
Correlation between allergen-specific IgE and allergen-
specific Th and B cells
Since production of allergen-specific IgE is characteristic
for allergic diseases, we determined serum concentration
of allergen-specific IgE using FEIA in 22 allergic and 12
non-allergic individuals. As expected, the absolute
counts of allergen-specific IgE were significantly higher
in individuals allergic to cat, Timothy or birch compared
to nonallergic individuals (Additional file 2, Figure S2).
Correlations between allergen-specific IgE and allergen-
specific Th cells but not allergen-specific B cells (specific
for cat, Timothy and birch) were statistically significant
(Table 2).
Indices and absolute counts of allergen-specific Th1 and
Th2 cells
No significant differences in the indices or absolute
counts of allergen-specific Th1 or Th2 cells between the
individuals allergic to any of the allergens analyzed and
nonallergic individuals were observed. There were
trends toward higher indices and absolute counts of
both allergen-specific Th1 cells and allergen-specific
Th2 cells in allergic compared to nonallergic individuals;
statistical significance was not reached probably due to
a high interindividual variabily in the number of aller-
gen-specific Th1 as well as Th2 cells.
Intraindividual variability of allergen-specific Th and B
cells (in blood drawn on different dates) is remarkably
low
In spite of the statistically significant difference in cat/
Timothy/birch-specific Th cell counts between allergic
and nonallergic individuals, there were cat/Timothy/
birch-allergic individuals with low cat/Timothy/birch-
specific Th cell counts (in the range of nonallergic indi-
viduals) as well as nonallergic individuals with high cat/
Timothy/birch-specfic Th cell counts (in the range of
allergic individuals) (Figure 6). This could be either due
to a high variability in assay results (due, eg, to variation
of allergen-specific Th cell counts from month to
month [eg, due to season or technical reasons] or
because allergen-specific Th cells were truly low in
some allergic individuals or truly high in some nonaller-
gic individuals. Also, the lack of statistically significant
difference in allergen-specific B cell counts between
allergic and nonallergic individuals could be due to a
high variability in assay results. Thus, we drew blood
from 5 cat/Timothy/birch-allergic individuals and 4
nonallergic individuals at ≥2 time points, and measured
allergen-specific Th and B cells at each time point. As
shown in Figure 5, the results were remarkably similar
between time points. This implies that (1) cat/Timothy/
birch-specific Th cell counts are high in most but not
all cat/Timothy/birch-allergic individuals and low in
most but not all nonallergic individuals, and (2) the lack
of statistically significant difference between allergen-
specific B cell counts in allergic vs nonallergic indivi-
duals is likely not due to a high variability of the assay
results.
Discussion
T h ep r e s e n ts t u d ys h o w st h r e ei m p o r t a n tf i n d i n g s .T h e
foremost among them is the similarity of allergen-speci-
fic proliferating B cell quantity (index or absolute count)
in allergic and nonallergic individuals. Irsch et al. and
Burastero et al. have also described similar frequency of
allergen-specific B cells in allergic vs nonallergic indivi-
duals; however absolute counts have not been deter-
mined in those studies [9,10]. Our data together with
those of Irsch et al. and Burastero et al. suggest that
since the quantity of allergen-specific B cells in blood is
not different between allergic and non-allergic indivi-
duals, other mechanisms like increased differentiation of
allergen-specific B cells into IgE-producing plasma cells
may be involved in the pathogenesis of allergic diseases.
This notion is further supported by the poor correlation
of allergen-specific B cell counts with serum levels of
allergen-specific IgE. Consistent with this speculation,
Kasaian et. al showed that allergic individuals have
higher frequencies of IgE-producing B cells in peripheral
blood than nonallergic individuals [6,7]. These are likely
the precursors of IgE-producing plasma cells that are
increased in number in the airways of allergic indivi-
duals [11].
The second crucial finding of this study is that the
quantity of cat, Timothy and birch-specific Th cells is
higher in allergic than nonallergic individuals and
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Figure 5 Ratio of positive control (anti CD3)-specific Th cell and allergen-specific Th cells (left) and ratio of positive control (anti CD3)-
specific B cells and allergen-specific B cells (right) in allergic patients (n = 33, closed diamonds) and nonallergic persons (n = 18, open
diamonds). The numbers of allergic patients were 18 for cat, 23 for Timothy, and 19 for birch. Significance of the difference between the allergic
and nonallergic groups is given in the upper section of each plot. The horizontal bars show the medians.
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and birch-specific IgE. We did not find a significant dif-
ference in the Th or B cell indices or absolute counts
between individuals allergic to other allergens (eg, dog,
D P )b u tt h i sm a yb ed u et ot h ei n a d e q u a t ep o w e rt o
detect a difference (data not shown). Specificity of aller-
gen-specific activation of Th cells was demonstrated by
showing that allergen-specific Th cells for all three aller-
g e n s( c a t ,T i m o t h y ,b i r c h )w as consistently higher in
allergic SPT+ than SPT- individuals and similar between
allergic SPT- and non-allergic individuals. In previous
studies allergen-specific Th cell quantities were also sus-
pected to be increased (based on increased thymidine
incorporation by MNCs or increased frequencies of pro-
liferating T cells stimulated with allergen) in persons
allergic to that allergen compared to nonallergic persons
in case of some allergens (eg, cow’sm i l kp r o t e i n ,p e a -
nut)[12-14] but not other allergens (eg, ovalbumin) [14].
However, absolute counts were not determined. In our
study, both indices and absolute counts for allergen spe-
cific Th cells have shown a similar pattern (significantly
different for cat, Timothy and birch). Consistent with
our results, Tay et al showed a higher frequency of pea-
nut-specific T cells in peanut-allergic individuals com-
pared to controls but similar frequency of egg allergen-
specific T cells in egg-allergic compared to nonallergic
subjects [14]. We speculate that in allergic persons, the
increased number of allergen-specific Th cells may drive
the allergen-specific B cells to differentiate into IgE
plasma cells. This may have been the reason why aller-
gen-specific Th cells showed consistently better correla-
tion with serum titer of allergen-specific IgE than
allergen-specific B cells.
The third important finding of the study is the simi-
larity in allergen-specific Th cell quantity when analyzed
at different time-points. This suggests that the interassay
variability is low and that the quantity of allergen speci-
fic Th cells remains relatively constant irrespective of
season or allergen exposure. More important, this sug-
gests that despite cat/Timothy/birch-allergic individuals
have higher-than-normal allergen-specific Th cell counts
a sag r o u p ,t h e r ea r es o m ec a t / T i m o t h y / b i r c h - a l l e r g i c
patients with low allergen-specific T cell counts and
some nonallergic patients with high allergen-specific T
cell counts. This suggests that the high allergen-specific
Th cell count is not the only pathogenic mechanism of
allergic disease, as other mechanisms may cause an indi-
vidual with low allergen-specific Th cell counts to
develop allergic disease or an individual with high aller-
gen-specific Th cell counts not to develop allergic
disease.
Table 2 Correlation between allergen-specific IgE
obtained from FEIA and absolute count of allergen-
specific Th and B cells
Allergen-specific IgE vs
Allergen-specific Th cells
Allergen-specific IgE vs
Allergen-specific B cells
Cat R = .58 R = .39
P = .004 P = .07
Timothy R = .72 R = .38
P <.001 P=.08
Birch R = .50 R = .21
P = .01 P = 76
1
10
100
1000
10000
100000
1000000
Sample 1 Sample 2
1
10
100
1000
10000
Sample 1 Sample 2
Allergic (SPT+)                                          Nonallergic
(B) Absolute count of allergen-specific B cells
1
10
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1000
10000
Sample 1 Sample 2 1
10
100
1000
Sample 1 Sample 2
(A) Absolute count of allergen-specific Th cell
P=0.89 P=0.40
P=0.85 P=0.89
Allergic (SPT+)                                          Nonallergic
Figure 6 Comparison of absolute count of (A) allergen-specific
Th and (B) allergen-specific B cells in blood drawn at different
time point from 5 allergic and 4 nonallergic individuals.
Significance of the difference between samples (1 and 2) collected
from same individual is given in the upper section of each plot. If
blood from a patient was drawn on more than two occasions,
sample 3 was considered as sample 1 or 2 for each of the other 2
samples. Allergen-specific Th and B cell results are displayed as
corrected absolute count of CFSE low Th and B cells (saline control
absolute counts subtracted).
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of our findings of no difference in the quantity of aller-
gen-specific B cells between allergic and nonallergic
individuals in case of all allergens tested. First, we
enumerated the allergen-specific B or Th cells in blood
and not in bone marrow, lymphoid and non-lymphoid
tissues like skin or mucosas. The non-blood tissues
might house the majority of allergen-specific memory
lymphocytes. So it is theoretically possible that allergic
individuals have higher numbers of allergen-specific B
c e l l si nt i s s u e sl i k et h ea i r w a ym u c o s ao rl y m p h o i d
organs like tonsils. Though, it is important to note in
this regard that the numbers of total lymphocytes, B
cells and CD4 T cells in airway secretions or biopsy spe-
cimens have been shown to be similar between allergic
and nonallergic individuals[15]. The second limitation is
that enumeration of allergen-specific B cells is based on
their proliferation. Other functions like production of
IgE have not been studied. The third limitation is that
our method of enumeration of the allergen-specific Th
or B cells was based on the ability of the cells to prolif-
erate. We assumed that all allergen-specific cells prolif-
erated and that their death rate during the 7 days of
culture was negligible. Fourth, for B cells, using a posi-
tive control stimulus directly stimulating B cells like
CD40L might have been advantageous. Fifth, we did not
take into account cell loss during cell staining (including
washes), as we considered this to be negligible and likely
similar between allergic and nonallergic individuals. The
correctness of these assumptions has not been tested.
Increased Th2 cell or decreased Th1 cell quantity or
function has been considered to play a role in the
pathogenesis of allergic disease [13,16-18] though this
has been recently contested [14]. The production of
IL-4 by IL-4-secreting Th cells (judged by anti-IL-4-PE
fluorescence of IL-4
+ cells) did not appear to be higher
in our allergic than nonallergic subjects, and the pro-
duction of IFNg by IFNg-secreting Th cells also did
not appear to be lower. Tay et al has also shown that
there were no significant differences in IFN-g or IL-4
producing cell numbers or in IFN-g/IL-4 ratios
between peanut- and egg- allergic and nonallergic
groups [14]. This suggests against a pathogenic role of
increased Th2 or decreased Th1 function. However,
the role of Th1 and Th2 cells cannot be conclusively
determined from our study, as the secretion of IL-4
and IFNg was measured after the cells were cultured
for 6-7 days - during this period their ability to secrete
IL-4 or IFNg m a yh a v ec h a n g e d .I ti sa l s oi m p o r t a n t
that only some, but not all T cell clones and lines spe-
cific for allergens that were cultured from peripheral
blood of allergic subjects have been shown to display
Th2 phenotypes [19-21].
Conclusions
The increased production of allergen-specific IgE in
patients with allergic asthma, rhinitis or eczema
probably does not result from an increased number of
allergen-specific B cells but might result from an
increased number of allergen-specific Th cells that
could stimulate differentiation of allergen-specific B cells
into IgE-producing plasma cells.
Additional material
Additional file 1: Figure S1: Absolute count for allergen-specific B
cells (left) and Th cells (right) in allergic SPT + patients (closed
diamonds), nonallergic persons (open diamonds), and allergic SPT -
patients (open circle). The allergic patients are divided into those
allergic to the allergen of interest per SPT result ("Allergic SPT+”) and
those allergic to a different allergen(s) ("Allergic SPT-”). The numbers of
Allergic SPT+ patients were 18 for cat, 23 for Timothy and 19 for birch.
The numbers of Allergic SPT- patients can be calculated for each allergen
as 39 minus the number of Allergic SPT+ patients (eg, 33-23 = 10 for
cat). Significance of the difference between the Allergic SPT+ and
Allergic SPT- groups and between Allergic SPT- and Nonallergic groups is
given in the upper section of each plot. The horizontal bars show the
medians.
Additional file 2: Figure S2: Allergen-specific IgE values analyzed by
FEIA in allergic (n = 22, closed diamonds) and nonallergic (n = 12,
open diamonds) individuals. The numbers of allergic individuals were
13 for cat, 11 for Timothy, and 12 for birch. Significance of the difference
between the allergic and nonallergic individuals is given in the upper
section of each plot. Undetectable IgE levels by FEIA are displayed as
0.05 kU/L. The horizontal bars show the medians.
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